Press "Enter" to skip to content

Agile Therapeutics exploring funding options after FDA meeting

(Reuters) – Agile Therapeutics Inc said on Friday it was looking for ways to fund operations after a meeting with the U.S. health regulator raised the possibility of a new clinical trial to test its stick-on contraceptive patch, Twirla.

Source: Health

Be First to Comment

Leave a Reply